👀 Ones to watch: The MOST undervalued stocks to buy right nowSee Undervalued Stocks

Texas sues Biden administration for asking pharmacies to fill reproductive health prescriptions

Published 02/07/2023, 08:15 PM
Updated 02/08/2023, 08:25 AM
© Reuters. FILE PHOTO: Anti-abortion protestors stand outside Women's Reproductive Clinic of New Mexico, in Santa Teresa, U.S., January 13, 2023. REUTERS/Evelyn Hockstein
CVS
-
WBA
-

By Kanishka Singh

WASHINGTON (Reuters) - Texas sued the administration of U.S. President Joe Biden on Tuesday to prevent it from asking pharmacies to fill reproductive health prescriptions.

The Biden administration said in July 2022 that refusing to fill prescriptions for drugs that could be used to terminate a pregnancy could violate federal law, regardless of various state bans on the procedure.

This guidance from the Biden administration, which involved roughly 60,000 U.S. retail pharmacies, came days after Biden signed an executive order easing access to services to terminate pregnancies after the U.S. Supreme Court overturned the Roe v. Wade ruling that made abortions legal nationwide.

The lawsuit was filed on Tuesday against the U.S. Department of Health and Human Services in the U.S. District Court for the Western District of Texas. The department did not immediately respond to a request for comment late on Tuesday.

"The Biden Administration knows that it has no legal authority to institute this radical abortion agenda, so now it's trying to intimidate every pharmacy in America by threatening to withhold federal funds," Texas Attorney General Ken Paxton said in a statement on Tuesday.

White House officials said in January that 60 anti-abortion bills have been filed in the 2023 legislative session and over 26 million women currently live in U.S. states that have banned abortion.

The Food and Drug Administration said January that abortion pills would become more widely available at pharmacies and through the mail. A legal battle is under way at a federal court in Texas, where abortion opponents have sued to undo the approval of the drugs.

© Reuters. FILE PHOTO: Anti-abortion protestors stand outside Women's Reproductive Clinic of New Mexico, in Santa Teresa, U.S., January 13, 2023. REUTERS/Evelyn Hockstein

A group of 20 Republican state attorneys general last week told Walgreens Boots Alliance (NASDAQ:WBA) Inc and CVS Health Corp (NYSE:CVS) that they risk running afoul of federal and state law if they dispense the abortion drug mifepristone by mail.

Walgreens and CVS have said they intend to become certified and dispense the drug in states where abortion is legal, though neither has yet done so.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.